Trapelo is the first, interoperable, decision-support platform used by oncologists, labs, and payers that informs testing and treatment and facilitates real-time alignment in precision medicine. Trapelo streamlines clinical workflow and prior authorization, enabling value-based care while quickly giving patients the most appropriate, evidence-supported options when time matters most.
Learn more about what Trapelo knows:
NEW WHITEPAPER
The Cost and Complexities of Treating Cancer are Astronomical—and on the Rise
Now, some US oncologists are collaborating with genomic labs and payers through an evidence-based technology to reduce treatment costs and improve patient outcomes. Read the abstract here.
Co-authors:
Debra Patt, M.D., Ph.D., MBA
Texas Oncology
Russ Ingersoll, Ph.D.
Trapelo Health
Listen to the award-winning podcast featuring today's precision medicine innovators.
.jpg)
Featured Guests:
-
Mr. Chet Burrell, formerly CareFirst Blue Cross Blue Shield
-
Dr. Jack West, City of Hope
-
Clynt Taylor, Trapelo Health
-
​Luba Greenwood, Google Life Sciences
Now in Season 5! Listen to the award-winning podcast featuring today's precision medicine innovators.
Hear from patient advocates, oncologists, educators, entrepreneurs, genomic scientists, pathologists, health plan executives and more:
-
Hilary Gee Goeckner, American Cancer Society Cancer Action Network
-
Trevor Maxwell, Man Up to Cancer and patient advocate
-
Dr. Douglas Flora, St. Elizabeth Healthcare, AI in Precision Oncology
-
Dr. Debra Patt, Texas Oncology
-
Dr. Luiz Raez, Memorial Cancer Institute
-
Dr. Pranil Chandra, PathGroup
-
Dr. Karen Winkfield, Meharry-Vanderbilt Alliance
-
​Dr. Kashyap Patel, Carolina Blood and Cancer Center
-
Lisa Goldman and Tori Tomalia, lung cancer patients and ROS1der founders
-
Dr. Christian Rolfo, International Society of Liquid Biopsy
-
Ali Rogin, PBS NewsHour and breast cancer previvor
-
Dr. Bruce Johnson, Dana Farber Cancer Institute